John H. Heiligenstein

Statistics

Publications

Citations

4.1K

H-Index

Active since

1992

Affiliations

Eli Lilly (United States)(Current)

Massachusetts General Hospital

The University of Texas Southwestern Medical Center

University of Nebraska Medical Center

Harvard University Press

John H. Heiligenstein is an author at Eli Lilly (United States) specializing in psychopharmacology, pharmacotherapy, and antidepressant pharmacotherapy.

Publications per year

1992–2006

Publications

Fluoxetine for Acute Treatment of Depression in Children and Adolescents: A Placebo-Controlled, Randomized Clinical Trial

Graham J. Emslie, John H. Heiligenstein, Karen Dineen Wagner et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2002 · 580 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Results From 2 Proof-of-Concept, Placebo-Controlled Studies of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder

Thomas Spencer, John H. Heiligenstein, Joseph Biederman et al. · The Journal of Clinical Psychiatry · 2002 · 336 citations

Medicine, Pharmacology, Pharmacotherapy +17

Fluoxetine Treatment for Obsessive-Compulsive Disorder in Children and Adolescents: A Placebo-Controlled Clinical Trial

Daniel Geller, S. Hoog, John H. Heiligenstein et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2001 · 323 citations

Medicine, Pharmacotherapy, Psychiatry +16

Atomoxetine and Methylphenidate Treatment in Children With ADHD: A Prospective, Randomized, Open-Label Trial

Christopher J. Kratochvil, John H. Heiligenstein, Thomas Spencer et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2002 · 294 citations

Medicine, Pediatrics, Psychiatry +14

Recovery from depression, work productivity, and health care costs among primary care patients

Dennis A. Revicki, John H. Heiligenstein, Louis C. Grothaus et al. · General Hospital Psychiatry · 2000 · 268 citations

Medicine, Psychiatry, Mental Health Care +15

1–5 of 37